ZOOM IN - Ⅳ
Developed a portable X-ray imaging
system as a revolutionary paradigm
change in medical examination in the
non-face-to-face era
Remedi Co. CEO Lee Rena
Language

Remedi Co.
General Status Implementing Agency National IT Industry Promotion Agency(NIPA) Business Details Promoting a digital content industry ecosystem (informatization)
Company Status CEO Lee Rena Business Type Manufacturing Year of Establishment July 7, 2012 Homepage https://remedihc.com/
Key Accomplishments Created a non-face-to-face X-ray imaging environment by developing portable X-ray imaging devices based on the 5G environment and contents that can utilize imaging data. Created a non-face-to-face X-ray imaging environment for Eunpyeong St. Mary’s Hospital, which was designated as a COVID-19 patient treatment center by the Seoul Metropolitan Government, and recorded sales of KRW 1 billion in the second half of 2020 by signing an exclusive sales contract with Dongguk Lifescience.
With COVID-19 spreading around the world, non-face-to-face life has become commonplace. Accordingly, various treatment methods in hospitals and clinics—which inevitably have to come in contact with patients directly—also required changes in various aspects.

Remedi Co., Ltd. paid attention to X-ray imaging. For X-ray image, installation-type image and diagnosis equipment are essential to process a huge amount of data. Remidi has developed a portable X-ray imaging device based on the 5G environment and an application that can process X-ray imaging data. As a result, Remidi paved the way for wirelessly performing X-ray imaging, which was the most limited in space.

Remedi provides a more convenient and safe examination environment to all patients and medical staff who need to do X-ray examinations as well as COVID-19 screening clinics and patient treatment centers by developing X-ray examination devices that can minimize contact between medical staff and confirmed patients.
Improving the quality of life by reinventing radiation
technology
image1
Remedi was established to popularize radiation imaging medical devices with the vision of “Improving the quality of life by reinventing radiation technology.” The company decided that it was necessary to improve the accessibility of radiation medical device services and develop high value-added products that meet the needs of customers. Accordingly, it focused on research on original technology that can meet the future demand for radiographic diagnostic examinations.
Remedi is spearheading innovation in the digital healthcare total solution field based on high-level radiation technology and various clinical experiences. It is also leading the global market using parts and materials for ultra-compact X-ray diagnostic devices and core technologies of the XIT platform.
Remedi provides the optimal system for each X-ray imaging and treatment industry, based on the key competitiveness and price competitiveness of the XIT platform technology, know-how on reducing the size, and rapid development capability. The company has developed and distributed portable X-ray imaging devices, which are essential in the non-face-to-face era, and is it is drawing considerable attention in the radiation diagnostic device industry.
Developing portable X-ray imaging technology that is
essential in the non-face-to-face era
The portable X-ray digital camera and handheld X-ray camera developed by Remedi provide a high degree of freedom for medical staff to take pictures just as easily with a portable camera, instead of the conventional method wherein the subject had to change positions on a fixed X-ray diagnostic device.
image2
When a portable X-ray imaging device is used, the medical staff need not instruct the subject to change position to find the desired image angle. The device is drawing great attention as it can be used in places such as screening clinics and patient treatment centers where the patient and the medical staff should minimize physical contact, such as the COVID-19 test.
Remedi has also implemented a chest X-ray imaging and non-face-to-face examination system essential for testing COVID-19 by developing digital content suitable for non- face-to-face use environments. Users can use the device conveniently because they can utilize an application that includes digital manuals and video content.
Leading the promotion of the digital content industry
by proposing the direction of future medical services
image3
The company plans to develop a technology that allows patients and medical staff to diagnose quickly without fear of contracting contagious diseases including COVID-19, while improving the interface with focus on user convenience.
Remedi has achieved remarkable results every year, such as getting selected as a promising SME in Gangwon-do in 2018, winning the silver award at the 2019 Gangwon Export Awards, receiving technical innovation-type SME certification (Inno-Biz) in 2020, getting selected as a promising export SME by the Ministry of SMEs and Startups in 2021, etc.
Remedi is expected to lead the future medical service optimized for the non-face-to-face era and which prioritizes user convenience and to make new history continuously in the field by developing an accurate, convenient X-ray imaging device.
MINI INTERVIEW

Q1. What did you achieve by participating in this project?
We developed an app and a program that can be linked with an X-ray imaging device using wireless communication technology. We implemented an X-ray system suitable for a non-face-to-face service environment using the app, which can be linked with a kiosk (like a screening clinic), and signed an exclusive sales contract with related hospitals and universities.
Q2. What was the key to the successful achievements?
I believe that we have quickly prepared for future demand based on high quality competitiveness, by forecasting changes in the market environment caused by COVID-19. In addition, we were able to reach the commercialization phase by significantly reducing the amount of radiation and providing convenience in mobility through continuous R&D.
TIME LINE
2021. 7

Selected as a company specializing in materials,
parts, and equipment
2020. 10

Certified as a technical innovation-type SME (Inno-Biz)
2020. 5

Receive item permission for the portable X-ray imaging device for medical services from the Ministry of Food and Drug Safety
2018. 4

The portable X-ray imaging device acquired US FDA certification
2016. 5

Receive item permission for the portable X-ray imaging device for
dental clinics from the Ministry of Food and Drug Safety
2012. 7

Incorporated Remedi
TOP
◀   Prev
Next   ▶